Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H E Hynes

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
Cancer|September 11, 1991
Alternating weekly doxorubicin and 5-fluorouracil/leucovorin followed by weekly doxorubicin and daily cyclophosphamide in stage IV breast cancer. A Southwest Oncology Group studyG K Ellis, S Green, S Schulman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1991
Objective antitumor activity of acivicin in patients with recurrent CNS malignancies: a Southwest Oncology Group trialS A Taylor, J Crowley, T W Pollock, et al.
Cancer Treatment Reports|May 1, 1987
Evaluation of fludarabine phosphate in renal cell carcinoma: a Southwest Oncology Group StudyL Balducci, B Blumenstein, D D Von Hoff, et al.
Investigational New Drugs|February 1, 1993
Mitogauzone, cisplatin, and vinblastine in advanced non-small cell lung cancer: a Southwest Oncology Group studyR Chapman, J Crowley, J G Lucas, et al.
Investigational New Drugs|May 1, 1990
Phase II study of fludarabine phosphate in multiple myeloma. A Southwest Oncology Group studyE H Kraut, J J Crowley, M R Grever, et al.
Gynecologic Oncology|August 1, 1992
Phase II trial of amonafide in previously treated patients with advanced ovarian cancer: a Southwest Oncology Group studyH H Gallion, P Y Liu, D E Alberts, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1997
Megestrol acetate and aminoglutethimide/hydrocortisone in sequence or in combination as second-line endocrine therapy of estrogen receptor-positive metastatic breast cancer: a Southwest Oncology Group phase III trialC A Russell, S J Green, J O'Sullivan, et al.
American Journal of Clinical Oncology|August 1, 1993
Evaluation of cisplatin and DTIC in inoperable stage III and IV melanoma. A Southwest Oncology Group studyW S Fletcher, D S Daniels, V K Sondak, et al.
Investigational New Drugs|May 1, 1990
5-day vinblastine infusion for pancreatic adenocarcinoma. A phase II Southwest Oncology Group studyJ T Guy, T Fleming, T W Pollock, et al.
The Journal of Urology|July 1, 1992
Combination cisplatin and dichloromethotrexate in patients with advanced bladder cancer. Phase 2. A Southwest Oncology Group studyF J Meyers, B Blumenstein, E D Crawford, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Cancer|September 11, 1991
Alternating weekly doxorubicin and 5-fluorouracil/leucovorin followed by weekly doxorubicin and daily cyclophosphamide in stage IV breast cancer. A Southwest Oncology Group studyG K Ellis, S Green, S Schulman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1991
Objective antitumor activity of acivicin in patients with recurrent CNS malignancies: a Southwest Oncology Group trialS A Taylor, J Crowley, T W Pollock, et al.
Cancer Treatment Reports|May 1, 1987
Evaluation of fludarabine phosphate in renal cell carcinoma: a Southwest Oncology Group StudyL Balducci, B Blumenstein, D D Von Hoff, et al.
Investigational New Drugs|February 1, 1993
Mitogauzone, cisplatin, and vinblastine in advanced non-small cell lung cancer: a Southwest Oncology Group studyR Chapman, J Crowley, J G Lucas, et al.
Investigational New Drugs|May 1, 1990
Phase II study of fludarabine phosphate in multiple myeloma. A Southwest Oncology Group studyE H Kraut, J J Crowley, M R Grever, et al.
Gynecologic Oncology|August 1, 1992
Phase II trial of amonafide in previously treated patients with advanced ovarian cancer: a Southwest Oncology Group studyH H Gallion, P Y Liu, D E Alberts, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1997
Megestrol acetate and aminoglutethimide/hydrocortisone in sequence or in combination as second-line endocrine therapy of estrogen receptor-positive metastatic breast cancer: a Southwest Oncology Group phase III trialC A Russell, S J Green, J O'Sullivan, et al.
American Journal of Clinical Oncology|August 1, 1993
Evaluation of cisplatin and DTIC in inoperable stage III and IV melanoma. A Southwest Oncology Group studyW S Fletcher, D S Daniels, V K Sondak, et al.
Investigational New Drugs|May 1, 1990
5-day vinblastine infusion for pancreatic adenocarcinoma. A phase II Southwest Oncology Group studyJ T Guy, T Fleming, T W Pollock, et al.
The Journal of Urology|July 1, 1992
Combination cisplatin and dichloromethotrexate in patients with advanced bladder cancer. Phase 2. A Southwest Oncology Group studyF J Meyers, B Blumenstein, E D Crawford, et al.
Pageof 4